Copper

CHEMBL55643 Phase 4 Одобрено Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
63.6 g/mol
LogP
Phase
4

An essential trace mineral required for many body functions including enzyme activity and iron metabolism. Copper supplements are used to prevent or treat deficiency and are being studied in conditions like age-related macular degeneration.

Молекулярная масса

63,5500 g/mol

TPSA

0,00 Ų

Терапевтические области

Механизм действия

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Механизм

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

2D Структура

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

[Cu]

InChI

InChI=1S/Cu

Molecular Formula

Cu

HBD / HBA

- / -

Вращаемые Связи

0

Тяжёлые Атомы

1

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Часто задаваемые вопросы

An essential trace mineral required for many body functions including enzyme activity and iron metabolism. Copper supplements are used to prevent or treat deficiency and are being studied in conditions like age-related macular degeneration.

Provides an essential mineral element required for numerous enzymatic reactions, structural proteins, and physiological processes. Supplementation addresses deficiency states.

Yes, Copper is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL55643. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 23978. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Медицинский отказ от ответственности

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.